"Well," as the Brigadier once said, "here we go again..."
Yes, it's that time again. Doctor Who will shortly be undergoing one of its periodic upheavals, both in front of and behind the cameras at the same time.
On Thursday 29th July 2021, just four days after announcing the format of its 13th Series and releasing a teaser-style trailer alongside a pre-recorded panel interview for Comic-Con 2021, the BBC announced not only that Jodie Whittaker would be bowing out with the 3rd of 3 'Specials', but that showrunner Chris Chibnall would also be leaving at the same time.
Hence, as with David Tennant and Russell T. Davies in 2009, and with Peter Capaldi and Steven Moffat in 2017, there'll be another changing of the guard before Doctor Who returns in time for its 60th anniversary in 2023.
Unlike with other shows, however, this changeover is not actually indicative of, nor the cause of, any sort of crisis. It's a feature, not a bug, and one that's baked in to the format of the continuing series, precisely so that the show can undergo a natural renewal and soft reboot every few years. Each new iteration is tasked not just with giving the show a fresh lick of paint, but with restating and redefining the tone and content of the show for the next few years.
The biggest and most obvious change, at least in front of the cameras, is of course in the recasting of the show's main character. Each new actor is cast to be as unlike their predecessor as they were from theirs.
Each such change is always accompanied by a frenzied flurry of speculative guesses and suggestions, often with the same few names circling the rumour mill, even when the actors in question never end up in the role, and in many cases, were never likely to. Fan choices for the actor to play the 14th Doctor are all depressingly predictable, unimaginative and unrealistic, especially the choices that are rooted in zeitgeisty point-scoring, which are equally as bad as the arse-clenchingly trad choices their champions decry.
Phoebe Waller-Bridge is on Netflix money, so's Michaela Coel (who is also in Marvel/Disney's orbit). Richard Ayoade's range stretches as far as playing Richard Ayoade (truly the Paul Daniels of casting picks du jour). Gemma Whelan, Kelly MacDonald and Vicky McClure are all fine actors, but no more than a stone's throw from the outgoing Doctor.
Jo Martin's 'fugitive Doctor' may be crying out for more screen time before the Chibnall era is out, but give her the job full time and where's your bold new era, distinct from the last, free to enjoy the inherent soft reboot that each behind the scenes changing of the guard could - and should - bring?For the sake of the show, we have to 'kill our darlings' and that means we have to let go of the fugitive Doctor when the 13th Doctor and her showrunner leave. If Chibnall were staying, maybe Jo Martin would be in with a shout, but he's not staying. Fact is, you don't bring in a fresh new production team and shackle them to their predecessor's leftovers.
Here we've hit on why it's pretty impossible - and therefore pointless - at this stage to meaningfully suggest who should or could be the next Doctor: we have no idea who the next showrunner, or showrunners, will be. We don't even know whether the same production team structure would be used.
It may be more likely that the BBC would want a Lead Writer/Executive Producer split instead of putting all their eggs in the basket of working one person into the ground.
Frankly we don't even know who they'd be working for.
Co-Production isn't a dirty word
Far too many Doctor Who fans, divorced from the realities of modern TV production and consumption, have a reactionary and Pavlovian aversion to the merest suggestion of any sort of co-production arrangement.
Whilst this is far from being the only way to produce Doctor Who, and is by no means without its drawbacks and challenges, it's also probably inevitable (all drama production must be outsourced by 2027 under latest Charter renewal edicts, and it's not clear that just using BBC Studios will necessarily cut it) and it's also probably the only answer to some otherwise insurmountable problems in terms of budget.
So without wishing to go with a "if not now, then when?" argument (🤮), the timing of the show's latest regeneration may present an opportunity that it would be negligent to ignore. At least, if the BBC fail to make plans for a smooth transition, another hiatus, possibly a lengthy one, could be a very real possibility as their funds are whittled away by a UK Government determined to do them down.
The most common objections are that "giving" the show to a streaming platform such as Netflix will mean:1. It gets cancelled after one or two series, never to return.
2. It'll be made by (gasp) Americans, or at least people who don't 'get' the show.
3. It's a betrayal of licence fee payers / will breach the BBC's charter.
Firstly, let's correct the entire premise there. There's never been any suggestion of selling off the whole kit and caboodle. That's just not what co-production means.
Co-production would mean another investor stumping up the cash to get the show made, for a return on their investment, if only in broadcast rights.
Bear in mind this doesn't even necessitate the actual hands-on making of the show to go outwith BBC Studios (at least at this stage), though that's possible too.
There are in fact clear precedents for this, with the likes of Terry Pratchett & Neil Gaiman's Good Omens being a co-production between BBC Studios, Amazon Studios and others, and His Dark Materials being made by Jane Tranter & Julie Gardner's Bad Wolf Productions with New Line Productions (a division of Warner Bros. Entertainment) for the BBC and HBO.
So let's look at those objections - 1. A quick cancellation
Whilst this may happen quite commonly at Netflix, there's no real reason to fear that that would really be likely if the co-funder is HBO or Amazon. The latter has just shelled out $465m for one series of their Lord of the Rings show, and acquired MGM Studios for $8.45bn, so they're not short of a few bob and like a bit of proven IP.
Amazon also streams Star Trek: Picard, not in fact a co-production, but exclusively broadcast in the US on Paramount+ and then streamed on Amazon Prime Video within 24hrs in over 200 other countries and territories around the world.
This objection seems to mainly derive from anxiety over the original cancellation of the 1963-1989 Series, and the collapse of the subsequent TV Movie co-production deal after Paul McGann was flattened by Roseanne. In both those cases, the BBC was simply unable to afford to make the show to a standard of production values that could hold up to the likes of contemporary US sci-fi shows like Star Trek: The Next Generation and The X-Files.
Since 2005, the BBC has managed, but with diminishing episodes per series, and with a UK Government continually seeking to greatly reduce their licence fee income, imposing conditions on the charter renewal that will require all BBC shows to be made by external production companies by 2027, and waging a culture war that attempts to normalize the frequent cries from lunatic right wing fringes to "defund the BBC".
If Doctor Who doesn't move to a co-production model sooner or later, then exactly how many more series do people think the BBC will be able to afford to make anyway?
The major case for moving to a co-production model is of course financial. Despite initial rumours that the BBC had been unhappy with lengthier-than-before delays between series under Steven Moffat, and that Chris Chibnall was hired as a 'closer' to guarantee a series every year like clockwork, it now seems apparent that (even allowing for the filming delays caused by Covid-19) Chibnall and his BBC paymasters only ever intended to make 3 series over 5 years.
In reality, even with Covid, this is still what's happening in practice, with that third series just split up differently, into 6 episodes, 2 standard specials and a lengthier one, as the equivalent of the 10 episodes in each of Chibnall's first two series.
Admittedly we've not had any repetition of the year long gap in 2016 between Series 9 and 10, but not only did the BBC not get a series per year from Chibnall, they clearly didn't want it, apparently not being able to afford it, or at least to afford to make it with that kind of turnaround in terms of how and when budgets were allocated.
The BBC may now count itself rather lucky that many of the Disney+ MCU and Star Wars shows favour 6 to 8 episode runs (a comparison you can surely expect them to employ soon and often the closer we get to the broadcast of Series 13), but let's see whether what we get really stacks up against the likes of The Mandalorian and the very Doctor Who-like Loki. We know not to expect movie-level budgets and effects, but even Doctor Who's production values don't come cheap.
If the BBC leave it too late to set up a co-production arrangement of some sort, there will eventually come a point where production grinds to a halt with no-one ready to pick up the reins. Sadly, operating hand to mouth and failing to future-proof itself does tend to be a hallmark of the BBC, another unwelcome effect of tight budgets and bureaucracy.
2. Makers who don't 'get' or respect the show
Highly unlikely. Whilst (e.g.) HBO/New Line/Amazon would likely insist on installing some Executive Producers to look after their investment and they could have some editorial style input, it's unlikely we'd really notice any difference between that and how things already work within the BBC.
Remember, if this is still BBC Studios involved in production, they already know the show. If it's e.g. Bad Wolf Productions, then yes, that's the same Jane Tranter and Julie Gardner that were instrumental in bringing the show back with Russell T. Davies in 2005. You couldn't actually wish for better keepers of the flame.
In any event, the BBC would be fiercely protective of their Intellectual Property, and would surely make keeping tight editorial control over it a main pillar of any deal.
Again, this anxiety seems rooted in the conflicting priorities of the TV Movie's co-producers. Don't forget that nonsense like a rapping TARDIS console with lips was exactly the kind of thing that the BBC vetoed out of hand in the past. It seems far more likely that any co-producer this time round would very much be buying into Doctor Who, not seeking to reinvent it.
3. The Licence Fee
Mostly this is just about the fear of others seeing it before you, but also a legitimate point that if the show is being made with licence fee payers' money then licence fee payers do need to get the bang for their buck.
This is where the example of Star Trek: Picard seems most salient. Provided first broadcast on BBC One, HBO, Amazon or whoever can broadcast or stream it outside the UK within 24hours and honour would be satisfied.
It should perhaps be noted, however, that this was not the case with Good Omens, where the BBC Two broadcast came after the show being streamed on Amazon, and no-one batted an eyelid about the licence fee or BBC Charter there.
On a similar theme, though, other commercial aspects could be a potential sticking point, for example in terms of merchandising rights. If the BBC retain control over their IP and can therefore continue to issue licenses as they see fit then no problem, but what if a co-producer (or at least investor) wants a piece of the action? Perhaps there's an easy enough solution in deeming everything pre-2023 as the 'legacy' version of the show, and the subject of total BBC control, and everything 2023 onwards, whilst a continuation of the existing show, is subject to different licensing agreements. Would this necessarily need to impact the likes of Big Finish, Character Options, Titan Comics and Panini?
Which Who?
There's just no way to predict what kind of Doctor Who the BBC intend to make following Chibnall and Whittaker's exits.
If it's business as usual - the same production hierarchy, with production entirely from BBC Studios - then it may be likely that the next showrunner is a relatively conservative pick, though perhaps the BBC will want a non-fan this time, and maybe it's even likely they'd want the first female showrunner.
The actor chosen to play the Doctor would likely be the more radical choice, although even then, the BBC will not want to risk being accused of painting the first female Doctor as a failure, and will be mindful that Jo Martin's casting a 'pseudo incarnation' of sorts doesn't really mean that the show has had a 'proper' non-white lead. Without any direct need to satisfy non-UK investors, there's not the same kind of pressure to cast a 'big' name actor. So your Doctor likely ends up being a female POC who's relatively unknown (think Matt Smith's pre-Who career), and they star in a series that is 6 episodes long, no more.
If there's an Anglo-centric co-production, possibly with a partner investor such as HBO, then the imperative for more of a star name as the show's lead raises its head, as does the question of what kind of production team runs the show - and in fact where.
You've got the likes of Nicola Schindler's Red Production Company with previous links to Russell T. Davies, Bad Wolf Productions with similar, and Lookout Point, in fact a part of the BBC Studios Group, whose CEO Faith Penhale has previous with Doctor Who (and Sherlock), and with links to the likes of Sally Wainwright and Mike Bartlett, who would both be seen - at least by the BBC - as the kind of prestige "Lead Writer" they'd be happy to have on board.
In that scenario, the Doctor is less likely to be an 'unknown' without at least one major hit under their belt, but still doesn't need to be 'internationally big', so the pond you're fishing in contains British actors who nevertheless would, on past form, be likely to bring in ratings of 6m+ week in week out for the BBC, and may be recognisable outside the UK for being in something else British. With the BBC theoretically still the bigger dog in the partnership at least on the creative front, again, they're not going to paint a target on their back by casting a male, but they could feel it was possible to cast another white female if they're of BAFTA-winner/national treasure standing. If there's HBO money on the go, 6 episodes is still likely, but 8-10 may also be possible.
If you get the 'Hollywood' scenario - Amazon backing, first broadcast for BBC One, 24hrs later for Amazon Prime outside the UK - then almost certainly the RTD-style "auteur" driven production model the show has stuck with between 2005 and (at least) the end of 2022 is likely done with.
A team of Consulting style Executive Producers for the BBC and Amazon would oversee hands-on Executive Producers operationally showrunning with a Lead Writer, and possibly a small writer's room, the likes of which apparently didn't really come off for Chibnall, and which is pretty unaffordable with the BBC going it alone.
Here, your Lead Writer could be practically anyone, with the choice to go with someone that's still perceived as being a prestige name in UK circles, or a suitably impressive young gun that doesn't have (nor need in this scenario) show-running experience, or even a 'name' from outside the UK provided the BBC are comfortable with their command of and affinity for the IP.
Your star would most likely have to be instantly recognisable to international audiences, likely with some film career and acclaim - but someone who is not unaffordable nor committed to Marvel or any other property with similar clout and cash reserves. It could in theory be possible that Amazon may overrule any BBC concerns about the gender of the casting, and that perhaps the BBC could be persuaded if a male of sufficient star standing were in the frame (a non-white male could be a compromise if so) but this is not to say that they'd be averse to casting another female Doctor by any means. Perhaps however, it's possible to say that at least the likelihood increases that in this scenario, the Lead Writer could be the more radical choice, and the lead actor the more conservative.
So what next?
Until the BBC make any sort of announcement or proof one way or the other leaks, all we can know is what we don't know. At time of writing, this includes:
1. What kind of Doctor Who the BBC want to make next.
2. How they want to make it (including how they intend to fund it).
3. Who they want to make it.
4. Where they want to make it.
5. Who they want to star in it.
Personally, until I know who's writing it, for whom, and how much is getting spent on it, I just find it really impossible to say what kind of actor (in terms of their personal characteristics and the standing of their career) it's sensible to think could end up in the role.
All we can do, is sit back, hope for the best, and see what the future brings!
